GlassScriptPhysician profile
Jerry P Gluckman
NPI 1629070370
$4,829.35
in general payments reported to CMS, 2019-2025
44 companies · $532 in 2025
The $532 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $986 · 2020: $305 · 2021: $958 · 2022: $708 · 2023: $618 · 2024: $722 · 2025: $532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,873.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,872.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $788.94 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $492.06 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Novo Nordisk INC | $449.77 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $341.55 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $296.24 | 2019-2025 | |
| Pfizer INC. | $273.85 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $225.16 | 2019-2024 | Verquvo, Belsomra, Gardasil |
| Bayer Healthcare Pharmaceuticals INC. | $192.25 | 2022-2024 | |
| Astellas Pharma US INC | $189.34 | 2019-2024 | Veozah |
| Abbott Laboratories | $137.31 | 2021-2025 | Freestyle Libre 3 |
| Janssen Pharmaceuticals, INC | $103.15 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $96.13 | 2019-2025 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $87.24 | 2021-2025 | Jardiance |
| Exact Sciences Corporation | $85.33 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sanofi-Aventis U.S. LLC | $80.91 | 2022-2023 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Gluckman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.